| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/16/2008 | CN100381083C Electronic nonflammable spraying cigarette |
| 04/15/2008 | US7358284 Particulate acellular tissue matrix |
| 04/15/2008 | US7358279 Concentrate containing lauryl glucoside; myristyl glucoside; polyglycerol-2-dipolyhydroxystearate; C12-24 fatty alcohol; oil; a diol, polyol or glycerol hydrotrope; and water; for impregnating substrates for body care, such as wipes and pads |
| 04/15/2008 | US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts |
| 04/15/2008 | US7358232 Using aqueous solution of water soluble antibiotic and surfactant; vaporizatio, evaportaion of water; forming deposits |
| 04/15/2008 | US7358226 The localized, targeted delivery of a drug or contrast agent for imaging by administering and concentrating a carrier by exposing it to a radiation force generated by ultrasound waves at a frequency and pressure combination; rupturing;affecting tissue permeability or altering cell physiology |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358068 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses; non-sequence complementary mode of action; drug screening |
| 04/15/2008 | US7357948 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 04/15/2008 | US7357947 With lipid fraction of lecithin or mixture of lecithin and triglycerides containing unsaturated fatty acids |
| 04/15/2008 | US7357945 Oral dosage form contains povidone or copovidone binder; HCl-free or non-hygroscopic filler; serotonin reuptake inhibition; stable without lose its hardness after storage |
| 04/15/2008 | US7357944 Liposomal analgesic drug compositions prepared in GMV using an ammonium sulfate gradient |
| 04/15/2008 | US7357943 Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient |
| 04/15/2008 | US7357937 Stability; gas delivery agent used in cosmetic or therapeutic product |
| 04/15/2008 | US7357930 Methods and formulations for targeting infectious agents bearing host cell proteins |
| 04/15/2008 | US7357923 Topical medicament for skin injuries and disorders |
| 04/15/2008 | US7357922 Microemulsion containing alkanolammonium salts of fatty alcohol sulfates and/or alkylpolyalkyleneglycoethersulfates |
| 04/15/2008 | US7357891 Process for making an ingestible film |
| 04/15/2008 | US7357810 High strength suture with absorbable core and suture anchor combination |
| 04/15/2008 | US7357336 Generation of therapeutic microfoam |
| 04/15/2008 | CA2566590C Cronotherapeutic diltiazem formulation and the administration thereof |
| 04/15/2008 | CA2454027C Residual solvent extraction method and microparticles produced thereby |
| 04/15/2008 | CA2401910C Hydrophilic molecular disperse solutions of carvedilol |
| 04/15/2008 | CA2372657C A method and apparatus for manufacturing dissolvable tablets |
| 04/15/2008 | CA2328920C Novel derivatives of 3,3-diphenylpropylamines |
| 04/15/2008 | CA2280629C Carotenoid formulations, comprising a mixture of .beta.-carotene, lycopene and lutein |
| 04/15/2008 | CA2215800C Self-emulsifying formulation producing a positively charged emulsion |
| 04/15/2008 | CA2200754C Process of making dosage units by wet granulation |
| 04/12/2008 | CA2563690A1 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 04/10/2008 | WO2008043024A2 Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease |
| 04/10/2008 | WO2008042802A2 Wet edible pearlescent film coatings |
| 04/10/2008 | WO2008042619A2 Self-preserved aqueous pharmaceutical compositions |
| 04/10/2008 | WO2008042454A1 Methods and ophthalmic devices used in the treatment of ocular allergies |
| 04/10/2008 | WO2008042452A1 Pharmaceutical compositions comprising oxytocin or an analog for the treatment of autism |
| 04/10/2008 | WO2008042331A2 Film embedded packaging and method of making same |
| 04/10/2008 | WO2008042216A2 Methods, kits, and compositions for generating new hair follicles and growing hair |
| 04/10/2008 | WO2008041970A2 Methods and compositions for targeting fenestrated vasculature |
| 04/10/2008 | WO2008041846A2 Hydroxyapatite tissue filler and its preparation and use |
| 04/10/2008 | WO2008041774A1 Sustained-release preparation having bone conduction ability |
| 04/10/2008 | WO2008041751A1 Pharmaceutical preparation for treating fibromyalgia |
| 04/10/2008 | WO2008041704A1 Controlled release preparation |
| 04/10/2008 | WO2008041553A1 Tacrolimus sustained-release preparation |
| 04/10/2008 | WO2008041514A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | WO2008041245A2 Injectable depot composition and it's process of preparation |
| 04/10/2008 | WO2008040841A1 A desiccant system for the regulation of humidity in inhalation powders |
| 04/10/2008 | WO2008040799A2 Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
| 04/10/2008 | WO2008040763A1 Pharmaceutical compositions comprising bisphosphonates |
| 04/10/2008 | WO2008040665A2 Capecitabine pediatric tablets |
| 04/10/2008 | WO2008040557A1 A spinal nucleus pulposus implant |
| 04/10/2008 | WO2008040556A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 04/10/2008 | WO2008040534A2 Non-mucoadhesive film dosage forms |
| 04/10/2008 | WO2008040512A2 Disposal system |
| 04/10/2008 | WO2008040488A1 Controlled release delivery system for nasal application of neurotransmitters |
| 04/10/2008 | WO2008040208A1 (2z)-2-(3,4-dihydroxybenzylidene)-1-benzofuran-3(2h)-one in manufacture of medicaments for treating cancers |
| 04/10/2008 | WO2008040187A1 Application of astilbin in preparation of medicament for treating or preventing acute or chronic renal failure, kidney fibrosis and diabetic renopathy |
| 04/10/2008 | WO2008040155A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 04/10/2008 | WO2008040149A1 Composition and method for treating immune-mediated skin disorders |
| 04/10/2008 | WO2008040094A1 Particle formation |
| 04/10/2008 | WO2008024389A3 Amphiphilic nucleotide cochleate compositions and methods of using the same |
| 04/10/2008 | WO2008020221A3 Topical application of fsh, lh, tsh or cg to the cervix |
| 04/10/2008 | WO2008019254A3 Reagents, methods and systems to suppress pro-inflammatory cytokines |
| 04/10/2008 | WO2008018796A3 Viscoelastic aqueous gels comprising microspheres |
| 04/10/2008 | WO2008012329A3 Seamless capsules containing high amounts of polyunsaturated fatty acids and a flavouring component |
| 04/10/2008 | WO2008011518A3 Encapsulation system |
| 04/10/2008 | WO2008006528A3 Pharmaceutical compositions comprising levetiracetam |
| 04/10/2008 | WO2008005352A3 Solid dose formulations of a thrombin receptor antagonist |
| 04/10/2008 | WO2007150074A3 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| 04/10/2008 | WO2007149802A3 Formulation for delivery of immune response modifiers |
| 04/10/2008 | WO2007144081A3 Smoking withdrawal combination wafer |
| 04/10/2008 | WO2007143311A3 Solid medicament dosage form consumption aid |
| 04/10/2008 | WO2007141344A3 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 04/10/2008 | WO2007137131A3 Delivery of active agents using a chocolate vehicle |
| 04/10/2008 | WO2007131577A3 Transdermal therapeutic system |
| 04/10/2008 | WO2007124465A3 Stable emulsion formulations |
| 04/10/2008 | WO2007122635B1 Controlled release formulation comprising anti-epileptic drugs |
| 04/10/2008 | WO2007109523A3 Stabilized ophthalmic compositions comprising oxidatively unstable components |
| 04/10/2008 | WO2007105071A3 Composition for cosmetic or pharmaceutical-dermatological use |
| 04/10/2008 | WO2007070569A3 Composition and regimen for the treatment of epidermal herpetic lesions |
| 04/10/2008 | WO2007061752A3 Biocompatible latent emulsifiers |
| 04/10/2008 | WO2007057762A3 Osmotic bi-layer tablet |
| 04/10/2008 | WO2006123314A3 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| 04/10/2008 | US20080086113 Medical devices having porous regions for controlled therapeutic agent exposure or delivery |
| 04/10/2008 | US20080086112 Microdevice for detecting, activating and delivering molecules |
| 04/10/2008 | US20080085994 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 04/10/2008 | US20080085929 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same |
| 04/10/2008 | US20080085364 Low cost equipment, high speed manufacturing; uniform particle size; covering openings of micropores |
| 04/10/2008 | US20080085325 Dialysis Solution, Formulated And Stored In Two Parts, Comprising Phosphate |
| 04/10/2008 | US20080085318 Coated compositions and methods for preparing same |
| 04/10/2008 | US20080085317 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions |
| 04/10/2008 | US20080085316 Crosslinked gelatin powder containing rehydration aid such as polyethylene glycol, polyvinylpyrrolidone, and dextran |
| 04/10/2008 | US20080085315 Amorphous ezetimibe and the production thereof |
| 04/10/2008 | US20080085314 Comprises controlled release acetaminophen, non-steroidal anti-inflammatory drug, and agent capable of reducing gastric acid secretion |
| 04/10/2008 | US20080085313 Administering an endothelin antagonist such as sitaxsentan; freeze drying |
| 04/10/2008 | US20080085312 Multi-Phase Release Potassium Guaiacolsulfonate Compositions |
| 04/10/2008 | US20080085311 Antihistamine-decongestant combinations |
| 04/10/2008 | US20080085310 Capecitabine rapidly disintegrating tablets |
| 04/10/2008 | US20080085309 Treated starch having a degree of gelatinization of 30-60% dispersed in the tablet also containing a drug, and a saccharide; rapid disintegrability, solubility, and appropriate hardness without using special fillers, apparatus; high strength; saccharide mixture of low/high moldibility powder and paste |
| 04/10/2008 | US20080085308 Granules Comprising Paracetamol, a Nsaid and a Sugar Alchohol Made by Melt Extrusion |
| 04/10/2008 | US20080085307 Matched, pre-divided tablet comprising more than one medication to be taken together after separation by removal of the connector; accuracy; convenience; efficiency; materials handling |
| 04/10/2008 | US20080085306 Topiramate compositions and methods of enhancing its bioavailability |